Search

everythinglearnresearchcommunity

for

Search:↓

Non-invasive imaging helped diagnose a woman's severe hormone imbalance and diabetes, and medication successfully treated her condition.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Minoxidil breakdown varies by enzymes, affecting hair loss treatment effectiveness.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Men with baldness have higher levels of specific proteins, suggesting local hormone production may play a role in hair loss.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Local skin glucocorticoid production is crucial for healthy skin, and its disruption can lead to skin diseases.

Early diagnosis and treatment of PCOS in young people is important to prevent long-term health problems.

A new method accurately measures steroid hormones in a few hair strands and could help study chronic stress and hair loss.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

A small number of premenopausal female blood donors had high prolactin levels, often due to stress, and retesting is recommended to prevent misdiagnosis.

The conclusion is that PCOS is a common cause of hirsutism in young obese women, and early treatment is important to reduce the risk of metabolic syndrome.

A new gene variant causes glucocorticoid resistance in a mother and son.

Early NAS level changes affect alcohol consumption vulnerability.

A woman's hair loss was linked to a rare hormone-secreting ovarian tumor, treated with surgery and hair loss medication.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.